These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17700052)

  • 1. The combination of buspirone and bupropion in the treatment of depression.
    Fava M
    Psychother Psychosom; 2007; 76(5):311-2. PubMed ID: 17700052
    [No Abstract]   [Full Text] [Related]  

  • 2. Psychopharmacology of smoking cessation in patients with mental illness.
    Selby P
    J Psychiatry Neurosci; 2006 Sep; 31(5):360. PubMed ID: 16951737
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of panic disorder with bupropion in a patient with Parkinson's disease.
    Gebhardt S; Röttgers H; Bäcker A; Schu U; Krieg JC
    J Clin Pharm Ther; 2008 Oct; 33(5):575-7. PubMed ID: 18834374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual hallucinations from the addition of riluzole to memantine and bupropion.
    Pittenger C; Naungayan C; Kendell SF; Coric V; Malison R; Krystal JH; Sanacora GS
    J Clin Psychopharmacol; 2006 Apr; 26(2):218-20. PubMed ID: 16633160
    [No Abstract]   [Full Text] [Related]  

  • 5. Bupropion in the management of apathy.
    Corcoran C; Wong ML; O'Keane V
    J Psychopharmacol; 2004 Mar; 18(1):133-5. PubMed ID: 15107198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication augmentation after the failure of SSRIs for depression.
    Trivedi MH; Fava M; Wisniewski SR; Thase ME; Quitkin F; Warden D; Ritz L; Nierenberg AA; Lebowitz BD; Biggs MM; Luther JF; Shores-Wilson K; Rush AJ;
    N Engl J Med; 2006 Mar; 354(12):1243-52. PubMed ID: 16554526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose buspirone, melatonin and low-dose bupropion added to mood stabilizers for severe treatment-resistant bipolar depression.
    Nierenberg AA
    Psychother Psychosom; 2009; 78(6):391-3. PubMed ID: 19738411
    [No Abstract]   [Full Text] [Related]  

  • 8. [Successful treatment of depression in a Parkinson disease patient with bupropion].
    Leentjens AF; Verhey FR; Vreeling FW
    Ned Tijdschr Geneeskd; 2000 Nov; 144(45):2157-9. PubMed ID: 11086491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nortriptyline toxicity secondary to interaction with bupropion sustained-release.
    Weintraub D
    Depress Anxiety; 2001; 13(1):50-2. PubMed ID: 11233461
    [No Abstract]   [Full Text] [Related]  

  • 10. Bupropion-induced sleepwalking.
    Oulis P; Kokras N; Papadimitriou GN; Masdrakis VG
    J Clin Psychopharmacol; 2010 Feb; 30(1):83-4. PubMed ID: 20075658
    [No Abstract]   [Full Text] [Related]  

  • 11. Does the presence of accompanying symptom clusters differentiate the comparative effectiveness of second-line medication strategies for treating depression?
    Gaynes BN; Farley JF; Dusetzina SB; Ellis AR; Hansen RA; Miller WC; Stürmer T
    Depress Anxiety; 2011 Nov; 28(11):989-98. PubMed ID: 21898717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bupropion-induced acute dystonia.
    Detweiler MB; Harpold GJ
    Ann Pharmacother; 2002 Feb; 36(2):251-4. PubMed ID: 11847943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder.
    Leuchter AF; Cook IA; Gilmer WS; Marangell LB; Burgoyne KS; Howland RH; Trivedi MH; Zisook S; Jain R; Fava M; Iosifescu D; Greenwald S
    Psychiatry Res; 2009 Sep; 169(2):132-8. PubMed ID: 19709754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression--augmentation or switch after initial SSRI treatment.
    Williams SC
    N Engl J Med; 2006 Jun; 354(24):2611-3; author reply 2611-3. PubMed ID: 16775879
    [No Abstract]   [Full Text] [Related]  

  • 15. Fatigue as a core symptom in major depressive disorder: overview and the role of bupropion.
    Pae CU; Lim HK; Han C; Patkar AA; Steffens DC; Masand PS; Lee C
    Expert Rev Neurother; 2007 Oct; 7(10):1251-63. PubMed ID: 17939764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bupropion as a possible treatment option for restless legs syndrome.
    Lee JJ; Erdos J; Wilkosz MF; LaPlante R; Wagoner B
    Ann Pharmacother; 2009 Feb; 43(2):370-4. PubMed ID: 19193596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of bupropion in the treatment of pemoline dependence.
    Martín Morgado B; Vaz Leal FJ; Bolívar Perálvarez M; Guisado Macías JA
    Actas Esp Psiquiatr; 2007; 35(4):277-8. PubMed ID: 17592792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wellbutrin versus generic bupropion.
    Med Lett Drugs Ther; 2008 Jul; 50(1290):54-5. PubMed ID: 18617874
    [No Abstract]   [Full Text] [Related]  

  • 19. Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder.
    Herrera-Guzmán I; Gudayol-Ferré E; Lira-Mandujano J; Herrera-Abarca J; Herrera-Guzmán D; Montoya-Pérez K; Guardia-Olmos J
    Psychiatry Res; 2008 Jul; 160(1):72-82. PubMed ID: 18501971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of combined estrogen and buspirone treatment in olivopontocerebellar atrophy.
    Heo JH; Lee ST; Chu K; Kim M
    J Neurol Sci; 2008 Aug; 271(1-2):87-90. PubMed ID: 18466925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.